Replication was necessary as aggravation of either acute seizures or the chronic process of epilepsy development by a compound acting at GPR39 is contrary to the prevailing hypothesis on GPR39 activation being a potential new therapeutic strategy for treating seizures/epilepsy [15]. The gene discussed is GPR39; the disease is epilepsy.